BIODELIVERY SCIENCES INTERNATIONAL

NC

Pharmaceutical company focusing in the areas of pain management and addiction medicine.

Active 2017–2022.

Filings
20
Filed By
1
Reported In-House
—
Reported By Firms
$607,500

Filings

All 202220212020201920182017
YearFirmPeriodAmountDoc
2022 JEFFREY J. KIMBELL & ASSOCIATES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination 		$30,000
2022 JEFFREY J. KIMBELL & ASSOCIATES, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$30,000
2021 JEFFREY J. KIMBELL & ASSOCIATES, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$30,000
2021 JEFFREY J. KIMBELL & ASSOCIATES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$30,000
2021 JEFFREY J. KIMBELL & ASSOCIATES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$30,000
2021 JEFFREY J. KIMBELL & ASSOCIATES, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$30,000
2020 JEFFREY J. KIMBELL & ASSOCIATES, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$30,000
2020 JEFFREY J. KIMBELL & ASSOCIATES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$30,000
2020 JEFFREY J. KIMBELL & ASSOCIATES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$30,000
2020 JEFFREY J. KIMBELL & ASSOCIATES, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$30,000
Page 1 of 2  ·  20 filings Next
Filed By
FirmFilingsAmount
JEFFREY J. KIMBELL & ASSOCIATES, INC. 20 $607,500
Issue Areas
IssueActivities
Health Issues 19
Alcohol and Drug Abuse 1
Medicare/Medicaid 1